US equities
|
MU
$878.84
▼-5.63%
NVDA
$214.13
▼-1.43%
TSLA
$354.72
▼-2.13%
AAPL
$343.46
▲+0.43%
META
$709.33
▼-3.72%
MSFT
$529.05
▼-1.93%
SPCX
$146.03
▼-1.74%
AMD
$528.75
▼-5.95%
MU
$878.84
▼-5.63%
NVDA
$214.13
▼-1.43%
TSLA
$354.72
▼-2.13%
AAPL
$343.46
▲+0.43%
META
$709.33
▼-3.72%
MSFT
$529.05
▼-1.93%
SPCX
$146.03
▼-1.74%
AMD
$528.75
▼-5.95%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Articles published by TriLink BioTechnologies
TriLink BioTechnologies® and Quantoom Biosciences Sign License and Supply Agreement for CleanCap® mRNA Capping Technology
June 03, 2025
From
TriLink BioTechnologies
Via
Business Wire
Tickers
MRVI
TriLink BioTechnologies® debuts its first mRNA synthesis kit with CleanCap® capping technology; Celebrates launch with kit donations to top academic institutions
May 20, 2025
From
TriLink BioTechnologies
Via
Business Wire
Tickers
MRVI
TriLink BioTechnologies® and the International Vaccine Institute Sign a Memorandum of Understanding to Support the Development of mRNA-based Vaccines
May 14, 2025
From
TriLink BioTechnologies
Via
Business Wire
Tickers
MRVI
Maravai LifeSciences Completes Acquisition of the DNA and RNA Business of Officinae Bio
February 24, 2025
From
TriLink BioTechnologies
Via
Business Wire
Tickers
MRVI
TriLink BioTechnologies® and Aldevron Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology
February 04, 2025
From
TriLink BioTechnologies
Via
Business Wire
Tickers
MRVI
TriLink BioTechnologies® & Alphazyme Collaborate to Launch New CleanScribe™ RNA Polymerase
September 24, 2024
From
TriLink BioTechnologies
Via
Business Wire
Tickers
MRVI
Cygnus Technologies and TriLink BioTechnologies® Collaborate to Launch AccuRes™ Host Cell DNA Quantification Kits
August 28, 2024
From
TriLink BioTechnologies
Via
Business Wire
Tickers
MRVI
TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center
May 13, 2024
From
TriLink BioTechnologies
Via
Business Wire
Tickers
MRVI
TriLink BioTechnologies® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology
April 30, 2024
From
TriLink BioTechnologies
Via
Business Wire
Tickers
MRVI
TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production
April 18, 2024
From
TriLink BioTechnologies
Via
Business Wire
Tickers
MRVI
TriLink BioTechnologies® Solidifies IP Position with Awarded Patents for CleanCap® Capping Technology in China and Canada
February 21, 2024
From
TriLink BioTechnologies
Via
Business Wire
Tickers
MRVI
TriLink BioTechnologies® Expands Capabilities with Launch of ‘Analytical Sciences Center of Excellence’
November 02, 2023
From
TriLink BioTechnologies
Via
Business Wire
Tickers
MRVI
TriLink BioTechnologies® Announces Manufacturing Capabilities Expansion as mRNA Manufacturing Facility Nears Completion
May 24, 2023
From
TriLink BioTechnologies
Via
Business Wire
Tickers
MRVI
